MAOB and astrocytoma (excluding glioblastoma): We sought to confirm previous finding that MAOB levels are higher in GBM and low-grade astrocytomas than in control brain tissue [14], to shed light as to why MAOB is upregulated in these cancers and to determine if the design and use of MAOB specific prodrugs is an appropriate route for glioma chemotherapy.